CYCN News and Press, Cyclerion Therapeutics Inc. From 05/25/21

CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that Company management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:00 p.m. ET. Management will also be available...

Creative Realities (CREX) +34%.Virgin Galactic Holdings (SPCE) +19% after successful weekend space flight.Strongbridge Biopharma (SBBP) +15% after being acquired by Xeris Pharma.Jiuzi Holdings (JZXN) +9%.Aptorum Group Limited (APM) +9% on positive interim phase I clinical trial...

Is It Time To Buy Penny Stocks After This Week’s Dip? Looking for penny stocks to buy right now? If you said “yes,” you’re not alone. In fact, retail traders have seemingly been frothing at the mouth to find a sustainable trend in small-cap stocks lately....

Insider buying increased significantly last week. Notable Insider Buys: Artisan Partners Asset Management Inc., American Assets Trust, Inc., Cyclerion Therapeutics, Inc., Lions Gate Entertainment Corp., Emclaire Financial Corp. Notable Insider Sells: Amazon.com, Inc., Facebook, In...

iBio (IBIO) +33% on COVID-19 study update.Orgenesis (ORGS) +11% on Q1 results.Chemomab Therapeutics (CMMB) +12%.T2 Biosystems, Inc. (TTOO) +11% on Q1 results.ViewRay (VRAY) +12%.Epizyme (EPZM) +11% on Q1 results.CureVac N.V. (CVAC) +9%.Roku (ROKU) +9% on Q1 results.Da...

At the webinar hosted by the company today, Cyclerion Therapeutics ([[CYCN]] -3.1%) shared the latest updates on its clinical programs for CY6463.The main programs in focus were the studies on Alzheimer's Disease with Vascular pathology (ADv), Cognitive Impairment Associated with Sc...

Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...

Provided updates on development strategy and execution for CY6463, a first-in-class, CNS-penetrant sGC stimulator, including IND clearance from FDA in ADv and ongoing MELAS program Introduced new CY6463 clinical program in CIAS with key insights from neuropsychiatric key opinion l...

CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, announced today the appointment of Errol De Souza, Ph.D., to its board of director...

Are These On Your List Of Penny Stocks To Buy Right Now? Everyone knows penny stocks can be risky. But with that higher risk comes the potential for higher rewards. Sure penny stocks under $0.50 that jump a quarter or more bring some big wins and great excitement to traders. How about t...